Phase 2 Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You are willing and able to sign a consent form agreeing to take part in the trial
- You have been diagnosed with active non-infectious anterior uveitis (inflammation at the front of the eye that is not caused by infection) that requires starting or increasing steroid eye drops to control the inflammation
- Your symptoms started within the last 4 weeks
Who may not be able to join:
- You have a serious eye condition in the eye being studied that could prevent you from completing the trial or affect the results, as decided by the doctor running the trial
- You have a history of, or currently have, cancer in or around your eye
- You have a type of eye inflammation affecting the middle or back of the eye, or other documented inflammation at the back of the eye
- Your uveitis is confirmed or strongly suspected to be caused by an infection, such as CMV, herpes simplex, herpes zoster, syphilis, tuberculosis, or Lyme disease
- You have a known allergy or sensitivity to either of the trial medicines: tacrolimus or semifluorinated alkanes (SFA)
- You are pregnant, breastfeeding, or planning to become pregnant
- You have any other condition or circumstance (for example, a language barrier, difficulty cooperating, or a history of substance misuse) that the trial doctor believes could put you at risk, affect the trial results, or make it difficult for you to participate (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sonja Kroesser, PhD, Novaliq GmbH
Phone: +49 622150259
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.